Bio-Techne
TECH
#1475
Rank
C$16.52 B
Marketcap
$103.97
Share price
-2.34%
Change (1 day)
31.93%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total debt

Total debt on the balance sheet as of September 2024 : C$0.55 Billion

According to Bio-Techne's latest financial reports the company's total debt is C$0.55 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Bio-Techne - Total debt on balance sheet (from 1999 to 2024)

Total debt by year

Year Total debt Change
2023-06-30C$0.60 B43.54%
2022-06-30C$0.41 B-19.44%
2021-06-30C$0.52 B-11.95%
2020-06-30C$0.59 B-10.71%
2019-06-30C$0.66 B48.74%
2018-06-30C$0.44 B-0.2%
2017-06-30C$0.44 B262.51%
2016-06-30C$0.12 B28.88%
2015-06-30C$95.6 M592.38%
2014-06-30C$13.8 M
2006-06-30C$14.96 M-16.39%
2005-06-30C$17.9 M-15.33%
2004-06-30C$21.14 M-8.14%
2003-06-30C$23.01 M-15.89%
2002-06-30C$27.36 M-4.61%
2001-06-30C$28.68 M-2.09%
2000-06-30C$29.29 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$49.51 B 8,752.20%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.94 B 247.97%๐Ÿ‡บ๐Ÿ‡ธ USA
C$27.09 B 4,743.85%๐Ÿ‡บ๐Ÿ‡ธ USA
C$24.57 B 4,292.88%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.96 B 251.36%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
C$27.93 B 4,894.01%๐Ÿ‡บ๐Ÿ‡ธ USA
C$4.91 M-99.12%๐Ÿ‡บ๐Ÿ‡ธ USA